HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Shen Selected Research

3,4-dihydroxytamoxifen

1/2000Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Shen Research Topics

Disease

36Neoplasms (Cancer)
10/2021 - 08/2000
8Inflammation (Inflammations)
01/2020 - 03/2009
7Body Weight (Weight, Body)
04/2014 - 09/2001
6Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2009
5Osteoporosis
02/2022 - 05/2010
5Hypertension (High Blood Pressure)
01/2022 - 01/2000
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2000
5Neoplasm Metastasis (Metastasis)
01/2018 - 01/2001
5Tuberculosis (Tuberculoses)
06/2011 - 09/2001
4Esophageal Squamous Cell Carcinoma
01/2022 - 06/2016
4Lymphoma (Lymphomas)
04/2021 - 04/2000
4Alzheimer Disease (Alzheimer's Disease)
01/2017 - 07/2013
4Pain (Aches)
01/2016 - 05/2010
4Infections
11/2014 - 08/2000
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2022 - 11/2004
3Adenocarcinoma
01/2022 - 11/2016
3Disease Progression
12/2020 - 01/2013
3Intervertebral Disc Degeneration
01/2020 - 11/2019
3Carcinogenesis
01/2018 - 01/2000
3Hypoxia (Hypoxemia)
01/2018 - 03/2005
3Melanoma (Melanoma, Malignant)
08/2017 - 02/2010
3Prostatic Neoplasms (Prostate Cancer)
01/2017 - 09/2013
3Type 2 Diabetes Mellitus (MODY)
11/2014 - 11/2003
3Atrophy
07/2013 - 03/2001
3Fibrosis (Cirrhosis)
05/2013 - 04/2009
3Breast Neoplasms (Breast Cancer)
01/2013 - 01/2000
3Weight Loss (Weight Reduction)
04/2005 - 11/2003
3Weight Gain
04/2005 - 11/2003
3Schistosomiasis japonica
08/2002 - 01/2000
2T-Cell Lymphoma (Lymphoma, T Cell)
04/2021 - 06/2001
2Fever (Fevers)
03/2020 - 02/2020
2Lymphatic Metastasis
01/2020 - 05/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2019 - 09/2017
2Nasopharyngeal Carcinoma
01/2019 - 01/2018
2Squamous Cell Carcinoma of Head and Neck
01/2019 - 06/2016
2Memory Disorders (Memory Loss)
01/2019 - 10/2015
2Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 01/2018
2Schizophrenia (Dementia Praecox)
11/2017 - 01/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2017 - 03/2016
2Atherosclerosis
01/2017 - 04/2010
2Carcinoma (Carcinomatosis)
04/2016 - 03/2016
2Insulin Resistance
11/2014 - 07/2012
2Non-alcoholic Fatty Liver Disease
06/2014 - 11/2011
2Viremia
05/2014 - 05/2001
2Ankylosing Spondylitis
11/2013 - 11/2012
2Chronic Hepatitis B
05/2013 - 04/2009
2Ischemia
12/2012 - 08/2005
2Infarction (Infarctions)
12/2012 - 08/2005
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
10/2009 - 04/2000
2Hypoglycemia (Reactive Hypoglycemia)
04/2005 - 12/2003
2Nausea
11/2004 - 12/2003

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2001
8AntigensIBA
01/2016 - 01/2000
7Insulin (Novolin)FDA Link
09/2020 - 11/2003
5Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2017
5Biological ProductsIBA
02/2021 - 01/2017
5Glucose (Dextrose)FDA LinkGeneric
09/2020 - 03/2001
4Phosphotransferases (Kinase)IBA
11/2020 - 01/2001
4AdiponectinIBA
09/2020 - 01/2013
4Cisplatin (Platino)FDA LinkGeneric
03/2016 - 01/2013
4CytokinesIBA
02/2014 - 01/2000
4pramlintide (Symlin)FDA Link
04/2005 - 11/2003
3Tuberculin (PPD)IBA
10/2020 - 09/2001
3Small Interfering RNA (siRNA)IBA
05/2019 - 03/2008
3cabazitaxelFDA Link
01/2017 - 09/2013
3DNA (Deoxyribonucleic Acid)IBA
03/2016 - 06/2004
3GlucocorticoidsIBA
05/2015 - 11/2004
3AntibodiesIBA
03/2015 - 04/2010
3Messenger RNA (mRNA)IBA
10/2013 - 02/2000
3Islet Amyloid PolypeptideIBA
11/2004 - 11/2003
3Hormones (Hormone)IBA
12/2003 - 01/2000
2ErbB Receptors (EGF Receptor)IBA
01/2022 - 06/2016
2PlatinumIBA
01/2022 - 03/2016
2Mitogen-Activated Protein KinasesIBA
01/2021 - 01/2018
2tyrosine receptor (receptor, tyrosine)IBA
11/2020 - 01/2001
2LeptinIBA
09/2020 - 09/2019
2Circular RNAIBA
03/2020 - 11/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2019 - 10/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 01/2013
2tramiprosateIBA
01/2017 - 01/2016
2Docetaxel (Taxotere)FDA Link
01/2017 - 09/2013
2Apolipoprotein E4IBA
01/2017 - 01/2016
2CoffeeFDA Link
05/2016 - 06/2014
2Caffeine (No Doz)FDA LinkGeneric
05/2016 - 11/2012
2Amyloid (Amyloid Fibrils)IBA
01/2016 - 03/2014
2IsoenzymesIBA
10/2015 - 08/2000
2Mitoxantrone (Novantrone)FDA LinkGeneric
04/2015 - 09/2013
2CholesterolIBA
04/2014 - 11/2012
2TamoxifenFDA LinkGeneric
01/2013 - 01/2000
2AutoantibodiesIBA
07/2012 - 04/2010
2Interferon-gamma (Interferon, gamma)IBA
08/2010 - 09/2009
2Oxygen (Dioxygen)IBA
03/2008 - 08/2005

Therapy/Procedure

25Therapeutics
04/2022 - 02/2000
17Drug Therapy (Chemotherapy)
01/2022 - 01/2000
4Transplantation
05/2022 - 09/2005
3Immunotherapy
10/2021 - 01/2019
3Castration
01/2017 - 09/2013
2Combination Drug Therapy (Combination Chemotherapy)
03/2020 - 02/2020
2Radiotherapy
04/2016 - 01/2013
2Lasers (Laser)
04/2016 - 06/2015